A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Entrepreneurship Guest Lecture Series
Publication date: Aug 28, 2012 02:11 PM
Start: Nov 22, 2012 05:15 PM
Alex Macpherson - Managing Director, Octopus Ventures
As head of the Ventures division of Octopus Investments, a firm which manages investments worth over £2 billion, Alex Macpherson has built his professional reputation on identifying, assessing and nurturing talented young businesses.
His team specialise in identifying emerging businesses with the potential for market disruption.